Altre lingue ARCA biopharma, Inc.

Azioni

ABIO

US00211Y5069

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 18/04/2024			Variaz. 5gg	Var. 1 gen.
3,25 ^USD	+1,25%		0,00%	+91,18%

04/04	ARCA biopharma, Inc. annuncia cambiamenti nella gestione	CI
04/04	ARCA biopharma, Inc. annuncia la separazione di Michael Bristow, Amministratore delegato	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

North American Morning Briefing : Stock Futures -2-	12:23
SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of ARCA Biopharma, Inc. - ABIO	10/04
ARCA BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of ARCA biopharma, Inc. - ABIO	05/04
ARCA biopharma, Inc. Announces Management Changes	04/04
ARCA biopharma, Inc. Announces Separation of Michael Bristow, Chief Executive Officer	04/04
Sector Update: Health Care Stocks Softer Late Afternoon	03/04
Shareholder Alert: Ademi LLP investigates whether ARCA biopharma, Inc. has obtained a Fair Price in its transaction with Oruka	03/04
Top Midday Gainers	03/04
Sector Update: Health Care Stocks Rise Wednesday Afternoon	03/04
Sector Update: Health Care	03/04
ARCA biopharma, Oruka Therapeutics Announce All-Stock Merger; Shares Surge	03/04
ABIO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of ARCA Biopharma, Inc. Is Fair to Shareholders	03/04
ARCA biopharma and Oruka Therapeutics Announce Merger Agreement	03/04
Oruka Therapeutics announced that it expects to receive $275 million in funding	03/04
ARCA biopharma Announces 2023 Financial Results	01/02
ARCA biopharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	01/02
ARCA biopharma Announces Third Quarter 2023 Financial Results	18/10/23
ARCA biopharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	18/10/23
ARCA biopharma announces Second Quarter 2023 Financial Results	24/07/23
ARCA biopharma Engages In Strategic Review Process	21/07/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue ARCA biopharma, Inc.

Azioni

ABIO

US00211Y5069

Altre lingue

Filtri